Treating Papillary Thyroid Cancers Raises Survival Slightly, but Significantly

Elsevier Global Medical News. 2010 May 17, MA Moon

Patients with papillary thyroid cancers that are limited to that gland are likely to have a favorable outcome regardless of whether they undergo rapid definitive treatment or are simply observed for disease progression, according to a report in the May issue of the Archives of Otolaryngology and Head and Neck Surgery. In an epidemiologic study using Surveillance, Epidemiology, and End Results (SEER) data on more than 35,000 papillary thyroid cancers (PTCs) diagnosed 1973-2005, 20-year survival was...

NOT A MEMBER?

Registration is FREE

  • Up-to-date oncology news
  • Journal article summaries
  • Commentaries and interviews
  • Drug and interactions database
  • Chemotherapy regimens
  • Daily e-newsletters

 

Meet Our Experts

Meet our Advisory and Editorial Boards comprised of physician editors and world-renowned experts.

Editors' Choice

Long-Term Posttransplant Bortezomib Boosts Outcome in Myeloma With del(17p13)

Cancer Type

  • Bladder
  • Bone
  • Breast
  • Breast (ER-Positive)
  • CNS/Brain
  • Colon and Rectum
  • Endocrine System
  • Esophagus
  • GYN (Non-Ovary)
  • GYN (Ovary)
  • Head and Neck
  • Hodgkin's Lymphoma
  • Kidney (Renal Cell)
  • Leukemia
  • Liver and Bile Duct
  • Lung
  • Multiple Myeloma
  • Myelodysplastic Syndrome
  • Myeloproliferative Diseases
  • Non-Hodgkin's Lymphoma
  • Pancreas
  • Pediatric Cancers
  • Prostate
  • Rare Cancers
  • Skin
  • Soft-Tissue Sarcoma
  • Stomach
  • Testicle
  • Forgot your password?
    Not a member? Free registration